Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr, a key indicator of kidney damage. 71% demonstrated improved or stabilized eGFR, signaling preserved...
Hence then, the article about palatin to present positive phase 2b data for melanocortin agonist in diabetic kidney disease at the national kidney foundation spring meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting )
Also on site :
- Casting News: The White Lotus Adds Max Greenfield And Four More, Last Of Us Casts Abby's Dad, And More
- Amazon's ‘Supportive’ Skechers Wedge Sandals Are ‘Great for Traveling’ and Just $31 Before the Big Spring Sale
- Beloved Singer-Songwriter Behind the Defining Rock Anthem of the 2000s Turns 51